USANA Health Sciences, Inc.
USNA
$27.18
$0.080.30%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.38% | -6.16% | -10.64% | -8.28% | -3.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.38% | -6.16% | -10.64% | -8.28% | -3.02% |
| Cost of Revenue | -8.90% | -7.69% | -6.91% | -11.23% | -8.85% |
| Gross Profit | -2.07% | -5.78% | -11.46% | -7.56% | -1.52% |
| SG&A Expenses | 7.96% | -5.13% | -9.26% | -7.48% | -2.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.34% | -5.69% | -8.78% | -8.30% | -4.16% |
| Operating Income | -66.10% | -11.39% | -26.89% | -8.09% | 7.40% |
| Income Before Tax | -60.81% | -9.37% | -24.64% | -4.88% | 16.70% |
| Income Tax Expenses | -39.61% | -12.88% | 2.66% | 4.51% | -1.62% |
| Earnings from Continuing Operations | -73.26% | -6.52% | -39.67% | -10.04% | 31.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.43% | -6.52% | -39.67% | -10.04% | 31.04% |
| EBIT | -66.10% | -11.39% | -26.89% | -8.09% | 7.40% |
| EBITDA | -55.00% | -8.18% | -21.60% | -7.67% | 4.98% |
| EPS Basic | -73.23% | -5.70% | -38.88% | -9.52% | 31.11% |
| Normalized Basic EPS | -60.69% | -8.58% | -23.67% | -4.34% | 16.77% |
| EPS Diluted | -73.72% | -5.70% | -39.33% | -9.47% | 31.99% |
| Normalized Diluted EPS | -60.69% | -8.00% | -23.58% | -4.74% | 16.77% |
| Average Basic Shares Outstanding | -0.77% | -0.87% | -1.28% | -0.57% | -0.05% |
| Average Diluted Shares Outstanding | -0.77% | -1.49% | -1.38% | -0.13% | -0.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |